Avanos Medical, Inc. AVNS 深 滬
已收盤 02-06 16:00:00 美东时间
14.59
+0.740
+5.34%
華盛通- 最 高14.61
- 今 開13.83
- 成交量 70.54万股
- 最 低 13.83
- 昨 收 13.85
- 總市值 6.77亿
- 52周最高 16.75
- 市盈率 靜 --
- 換手率 1.52%
- 52周最低 9.303
- 委 比 -25.00%
- 總股本 4641.89万
- 歷史最高 72.96
- 量 比 1.15
- 振 幅 5.63%
- 歷史最低 9.303
- 每 手 1
- 風險率 1.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospi...
02-03 21:00
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
ENvue Medical appoints Marc Waldman as Vice President, Commercial, leveraging his 35+ years of experience in the medical device industry to expand its enteral care platform in the U.S. Mr. Waldman will focus on growing the company's presence in 38 hospitals and accelerating revenue. His expertise in patient safety, enteral feeding, and neonatal nutrition aligns with ENvue's mission to advance non-invasive solutions for enteral care. **Summary** ...
01-21 13:30
AVITA Medical Announces Changes to its Board of Directors
AVITA Medical announced the appointment of Joe Woody as a non-executive director and the retirement of Lou Panaccio after over a decade of service. Woody, with extensive experience in global med-tech leadership, brings valuable insights to the company's growth strategy. Panaccio's contributions have been significant in shaping the company's commercial and operational strategy. AVITA Medical specializes in therapeutic acute wound care solutions, i...
01-05 21:05
Avanos Medical shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 guidance above estimates.
Avanos Medical shares are trading higher after the company reported better-than...
2025-11-05 22:30
Avanos Medical Raises FY2025 Adj EPS Guidance from $0.75-$0.95 to $0.85-$0.95 vs $0.80 Est; Raises FY2025 Sales Guidance from $665.000M-$685.000M to $690.000M-$700.000M vs $676.000M Est
Avanos Medical (NYSE:AVNS) raises FY2025 Adj EPS guidance from $0.75-$0.95 to $0.85-$0.95 vs $0.80 analyst estimate. Raises FY2025 sales outlook from $665.000 million-$685.000 million to $690.000 million-$700.000 million
2025-11-05 20:06
百强械企：出售业务、裁撤高管
来源：器械之家 日前，爱诺生医疗（Avanos Medical）宣布：将出售美国 Game Ready 骨科租赁业务核心资产，裁撤首席商务官（CCO）与总法律...
2025-10-26 07:56
Avanos Medical To Sell US Game Ready Orthopedic Rental Operations To WRS Group; Financial Terms Not Disclosed
WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avanos Medical, Inc. (NYSE: AVNS) to acquire substantially all assets
2025-10-23 20:15
Avanos Medical Acquires Nexus Medical for Growth
Avanos Medical ( ($AVNS) ) has shared an update. On September 15, 2025, Avanos ...
2025-09-15 19:29
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately he...
2025-09-15 19:00
Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs
Kimberly-Clark will pay $40.4 million to settle a criminal charge after selling mislabeled surgical gowns.
2025-08-30 00:53
